Compare StocksABBV vs IRM

AbbVie Inc. (ABBV) vs Iron Mountain Incorporated (IRM): Which Is the Better Buy in 2026?

As of 2026-08-03, ABBV is overvalued at $247, with a DCF intrinsic value of $178 and a margin of safety of -38%. IRM is overvalued at $125, with an intrinsic value of $0 and a margin of safety of -100%. Of the two, ABBV has the wider margin of safety.

ABBV
AbbVie Inc.
$246.91
VS
IRM
Iron Mountain Incorporated
$125.34

Rewards

ABBV
  • AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 72.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
IRM

    Risks

    ABBV
    • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
    • Free cash flow has declined at a 9.8% CAGR over the past 4 years — a concerning trend.
    IRM
    • PEG ratio of 2.70 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
    • Net debt/EBITDA of 7.9x indicates heavy leverage — it would take over 4 years of EBITDA to pay off net debt.
    • Altman Z-Score of 0.83 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.

    Key Valuation Metrics

    Learn more →
    ABBV
    IRM
    Valuation
    N/A
    Free Cash Flow
    $-499.46M
    N/A
    FCF Yield
    -1.34%
    69.75
    Trailing P/E
    136.24
    15.16
    Forward P/E
    46.85
    Quality & Moat
    27.60%
    ROIC
    6.08%
    N/A
    ROE
    N/A
    72.79%
    Gross Margin
    55.02%
    0.41
    PEG Ratio
    2.70
    Balance Sheet Safety
    N/A
    Net Debt / Equity
    N/A
    N/A
    Interest Coverage
    N/A
    2.06
    Net Debt / EBITDA
    7.95
    2.76%
    Dividend Yield
    2.83%
    ABBV: 6Ties: 2IRM: 0
    ABBVIRM

    Historical Fundamentals

    Learn more →
    ABBV

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    IRM

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    $1 Retained Earnings Test

    Learn more →
    ABBV
    N/A
    Net losses over 3 years — test not applicable
    Company had negative cumulative retained earnings
    Σ Retained
    $-19.85B
    Δ Market Cap
    +$118.02B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
    IRM
    N/A
    Net losses over 3 years — test not applicable
    Company had negative cumulative retained earnings
    Σ Retained
    $-1.94B
    Δ Market Cap
    +$10.04B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Discounted Cash Flow (DCF) Analysis

    Learn more →
    ABBV
    38.5% Overvalued
    Price is 38.5% above estimated fair value
    Current Price: $246.91
    Fair Value: $178.31
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued
    IRM
    Insufficient Data
    Enter initial FCF to calculate intrinsic value
    Current Price: $125.34
    Fair Value: $0.00
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued

    Reverse DCF — Market-Implied Growth

    Learn more →
    ABBV

    Requires positive FCF to compute implied growth rate.

    IRM

    Requires positive FCF to compute implied growth rate.

    Economic Moat Score

    Learn more →
    ABBV
    82/100
    Wide Moat
    70+ Wide · 40-69 Narrow · <40 None

    Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
    IRM
    51/100
    Narrow Moat
    70+ Wide · 40-69 Narrow · <40 None

    Narrow moat with revenue predictability as the key competitive advantage. Improving roic consistency would strengthen the moat.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

    Forensic Accounting

    Learn more →
    ABBV
    -2.86
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
    IRM
    -2.66
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Ownership Breakdown

    Learn more →
    ABBV
    Insiders 0.1%Institutions 76.9%Retail & Other 23.0%
    No. of Institutional Holders5,146
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
    IRM
    Insiders 0.9%Institutions 87.5%Retail & Other 11.6%
    No. of Institutional Holders1,493
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

    High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

    Insider Buying Activity

    Learn more →
    ABBV
    0
    Buys (3M)
    0
    Buys (12M)
    No open market insider purchases found.
    Open market purchases · includes direct & indirect ownership · excludes option exercises
    IRM
    0
    Buys (3M)
    1
    Buys (12M)
    Total value (12M): $2,954
    KELLY CHRISTIE BARTON
    Director
    $2,954
    @ $89.52 · 2025-11-19
    Open market purchases · includes direct & indirect ownership · excludes option exercises

    Open market purchases · includes direct & indirect ownership · excludes option exercises.

    Insider Selling Activity

    Learn more →
    ABBV
    0
    Sells (3M)
    5
    Sells (12M)
    Total value (12M): $21.79M
    PURDUE DAVID RYAN
    Officer
    $1.22M
    @ $233.56 · 2026-03-04
    SIATIS PERRY C.
    General Counsel
    $4.38M
    @ $234.39 · 2026-03-02
    SIATIS PERRY C.
    General Counsel
    $5.15M
    @ $230.00 · 2026-02-25
    SALEKI-GERHARDT AZITA
    Chief Operating Officer
    $8.41M
    @ $198.42 · 2025-08-12
    DONOGHOE NICHOLAS
    Officer
    $2.64M
    @ $198.51 · 2025-08-05
    STEWART JEFFREY RYAN
    Officer
    $12.36M
    @ $210.08 · 2025-03-31
    REENTS SCOTT T.
    Chief Financial Officer
    $3.75M
    @ $212.34 · 2025-03-14
    SIATIS PERRY C.
    General Counsel
    $5.82M
    @ $208.69 · 2025-03-03
    GONZALEZ RICHARD A
    Director
    $20.26M
    @ $205.45 · 2025-03-03
    RICHMOND TIMOTHY J
    Officer
    $4.47M
    @ $210.45 · 2025-03-03
    BUCKBEE KEVIN K
    Officer
    $3.85M
    @ $203.41 · 2025-02-26
    RICHMOND TIMOTHY J
    Officer
    $6.07M
    @ $202.90 · 2025-02-26
    SIATIS PERRY C.
    General Counsel
    $1.14M
    @ $197.90 · 2025-02-20
    BUCKBEE KEVIN K
    Officer
    $310,032
    @ $172.24 · 2024-12-16
    GONZALEZ RICHARD A
    Officer and Director
    $12.40M
    @ $186.52 · 2024-08-05
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
    IRM
    9
    Sells (3M)
    30
    Sells (12M)
    Total value (12M): $114.61M
    MEANEY WILLIAM L
    Chief Executive Officer
    $4.73M
    @ $122.83 · 2026-07-01
    KIDD MARK
    Officer
    $753,720
    @ $125.62 · 2026-07-01
    MEANEY WILLIAM L
    Chief Executive Officer
    $4.91M
    @ $127.55 · 2026-06-01
    KIDD MARK
    Officer
    $760,200
    @ $126.70 · 2026-06-01
    BORGES DANIEL
    Officer
    $902,220
    @ $125.50 · 2026-05-21
    RAKOWICH WALTER C.
    Director
    $94,209
    @ $124.45 · 2026-05-20
    ARWAY PAMELA M.
    Director
    $244,011
    @ $128.97 · 2026-05-12
    KIDD MARK
    Officer
    $767,460
    @ $127.91 · 2026-05-08
    MEANEY WILLIAM L
    Chief Executive Officer
    $4.96M
    @ $128.93 · 2026-05-08
    MEANEY WILLIAM L
    Chief Executive Officer
    $3.95M
    @ $102.71 · 2026-04-01
    KIDD MARK
    Officer
    $616,260
    @ $102.71 · 2026-04-01
    BHARGAVA MITHU
    Officer
    $6.25M
    @ $104.62 · 2026-03-19
    MEANEY WILLIAM L
    Chief Executive Officer
    $10.48M
    @ $106.25 · 2026-03-05
    MEANEY WILLIAM L
    Chief Executive Officer
    $21.13M
    @ $107.10 · 2026-03-04
    MEANEY WILLIAM L
    Chief Executive Officer
    $15.00M
    @ $109.39 · 2026-03-02
    KIDD MARK
    Officer
    $643,620
    @ $107.27 · 2026-03-02
    ALLERTON JENNIFER
    Director
    $762,160
    @ $108.88 · 2026-03-02
    MEANEY WILLIAM L
    Chief Executive Officer
    $4.16M
    @ $108.17 · 2026-02-20
    KIDD MARK
    Officer
    $649,020
    @ $108.17 · 2026-02-20
    MEANEY WILLIAM L
    Chief Executive Officer
    $3.20M
    @ $83.17 · 2026-01-02
    KIDD MARK
    Officer
    $498,600
    @ $83.10 · 2026-01-02
    MEANEY WILLIAM L
    Chief Executive Officer
    $5.76M
    @ $83.34 · 2025-12-01
    KIDD MARK
    Officer
    $510,000
    @ $85.00 · 2025-12-01
    KIDD MARK
    Officer
    $615,060
    @ $102.51 · 2025-11-03
    MEANEY WILLIAM L
    Chief Executive Officer
    $7.10M
    @ $102.75 · 2025-11-03
    KIDD MARK
    Officer
    $736,591
    @ $100.82 · 2025-10-31
    KIDD MARK
    Officer
    $609,780
    @ $101.63 · 2025-10-01
    MEANEY WILLIAM L
    Chief Executive Officer
    $7.07M
    @ $102.34 · 2025-10-01
    MEANEY WILLIAM L
    Chief Executive Officer
    $6.19M
    @ $89.56 · 2025-09-03
    KIDD MARK
    Officer
    $546,300
    @ $91.05 · 2025-09-02
    KIDD MARK
    Officer
    $583,200
    @ $97.20 · 2025-08-01
    MCINTOSH GREG W
    Officer
    $1.69M
    @ $97.20 · 2025-08-01
    MEANEY WILLIAM L
    Chief Executive Officer
    $6.54M
    @ $94.55 · 2025-08-01
    KIDD MARK
    Officer
    $612,120
    @ $102.02 · 2025-07-01
    MCINTOSH GREG W
    Officer
    $1.73M
    @ $100.00 · 2025-07-01
    MEANEY WILLIAM L
    Chief Executive Officer
    $6.94M
    @ $100.36 · 2025-07-01
    RAKOWICH WALTER C.
    Director
    $89,973
    @ $99.97 · 2025-06-04
    MCINTOSH GREG W
    Officer
    $1.70M
    @ $98.19 · 2025-06-02
    MEANEY WILLIAM L
    Chief Executive Officer
    $6.83M
    @ $98.77 · 2025-06-02
    MCINTOSH GREG W
    Officer
    $807,384
    @ $96.14 · 2025-05-22
    MEANEY WILLIAM L
    Chief Executive Officer
    $6.64M
    @ $96.09 · 2025-05-02
    MEANEY WILLIAM L
    Chief Executive Officer
    $5.95M
    @ $86.11 · 2025-04-01
    MEANEY WILLIAM L
    Chief Executive Officer
    $21.25M
    @ $89.50 · 2025-03-04
    MEANEY WILLIAM L
    Chief Executive Officer
    $21.25M
    @ $89.50 · 2025-03-04
    BHARGAVA MITHU
    Officer
    $161,356
    @ $92.84 · 2025-03-03
    BORGES DANIEL
    Officer
    $597,240
    @ $92.84 · 2025-03-03
    MEANEY WILLIAM L
    Chief Executive Officer
    $15.76M
    @ $91.33 · 2025-03-03
    MEANEY WILLIAM L
    Chief Executive Officer
    $6.90M
    @ $99.83 · 2025-02-03
    MEANEY WILLIAM L
    Chief Executive Officer
    $7.25M
    @ $104.85 · 2025-01-02
    BHARGAVA MITHU
    Officer
    $863,401
    @ $104.49 · 2024-12-23
    MEANEY WILLIAM L
    Chief Executive Officer
    $3.60M
    @ $113.55 · 2024-12-11
    MEANEY WILLIAM L
    Chief Executive Officer
    $3.76M
    @ $118.47 · 2024-11-11
    MEANEY WILLIAM L
    Chief Executive Officer
    $3.73M
    @ $117.52 · 2024-10-08
    MEANEY WILLIAM L
    Chief Executive Officer
    $3.70M
    @ $116.43 · 2024-09-18
    MURDOCK WENDY J
    Director
    $989,230
    @ $116.38 · 2024-09-17
    MARSON DEBORAH
    General Counsel
    $406,296
    @ $112.86 · 2024-09-03
    MEANEY WILLIAM L
    Chief Executive Officer
    $3.46M
    @ $109.08 · 2024-08-20
    BAKER-GREENE EDWARD
    Officer
    $248,254
    @ $109.75 · 2024-08-20
    TOMOVCSIK JOHN
    Chief Operating Officer
    $110,000
    @ $110.00 · 2024-08-19
    MARSON DEBORAH
    General Counsel
    $498,741
    @ $107.58 · 2024-08-09
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

    🎭 Mr. Market's Mood

    Learn more →
    ABBV
    FearGreed
    😐Neutral(59/100)

    "Market is pricing this stock without strong emotion in either direction"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
    IRM
    FearGreed
    😐Neutral(60/100)

    "Market is pricing this stock without strong emotion in either direction"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    ⚖️ Buffett Signal

    Learn more →
    ABBV
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Neutral (59)
    IRM
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Neutral (60)
    View ABBV Full AnalysisView IRM Full Analysis

    Frequently Asked Questions: ABBV vs IRM

    Is AbbVie Inc. or Iron Mountain Incorporated more undervalued in 2026?

    Based on our discounted cash flow model, ABBV trades at a -38.5% margin of safety (intrinsic value $178 vs. price $247), compared to IRM's -100.0% margin of safety (intrinsic $0 vs. $125).

    Which stock has a wider economic moat, AbbVie Inc. or Iron Mountain Incorporated?

    ABBV scores 82/100 (Wide moat), while IRM scores 51/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

    Is Iron Mountain Incorporated in financial distress?

    IRM's Altman Z-Score of 0.8 places it in the Distress zone, signaling elevated bankruptcy risk. ABBV scores 2.4 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

    Which stock has higher return on invested capital, AbbVie Inc. or Iron Mountain Incorporated?

    ABBV earns 27.6% ROIC versus IRM's 6.1%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

    Which dividend is safer, AbbVie Inc.'s or Iron Mountain Incorporated's?

    IRM's dividend earns a safety score of 39/100 (Unsafe), compared to ABBV's 39/100 (Unsafe). IRM has raised its dividend for 3 consecutive years.